Some infections no longer respond to common antibiotics because of antimicrobial resistance. Learn how resistance genes work, ...
New Delhi: Infections that once responded to commonly prescribed antibiotics may now require stronger medicines or ...
A new computational study of Pseudomonas aeruginosa shows that transient population dynamics and inoculum size fundamentally ...
A clinical image case in the Journal of General Internal Medicine describes a woman whose abdominal drain fluid turned ...
Pseudomonas aeruginosa is a common culprit in hospital-acquired bacterial infections and is growing more resistant to ...
A joint research team has identified a new mechanism underlying antibiotic resistance in Pseudomonas aeruginosa, a major ...
Issued patents provide intellectual property protection for clinical candidates, AP-SA02 and AP-PA02, until at least 2041. LOS ANGELES, Oct. 7, 2026 // -- Armata Pharmac ...
Merck has announced that it will no longer manufacture or market the antibacterial combination drug Recarbrio as “part of an ongoing review of its portfolio and unrelated to any product safety or ...
Armata Pharmaceuticals, Inc. announced issuance of two patents by the United States Patent and Trademark Office ("USPTO") covering its bacteriophage programs, AP-SA02 and AP-PA02. These newly issued U ...
A joint research team led by Professor Hongbaek Cho of the Department of Biological Sciences at Sungkyunkwan University (SKKU) and Professor Jeong Min Chung of the Department of Biotechnology at The ...
At the University of Oregon, researchers reconstructed proteins that existed as far back as 160 million years ago and found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results